These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22319069)

  • 61. Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis.
    Goel SS; Dilip Gajulapalli R; Athappan G; Philip F; Gupta S; Murat Tuzcu E; Ellis SG; Mishkel G; Kapadia SR
    Catheter Cardiovasc Interv; 2016 May; 87(6):1080-91. PubMed ID: 26613637
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of early and late target lesion revascularization after drug-eluting stent implantation.
    Choi IJ; Park HJ; Seo SM; Koh YS; Lee JM; Chang K; Chung WS; Seung KB; Kim PJ
    J Interv Cardiol; 2013 Apr; 26(2):137-44. PubMed ID: 23163343
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison between drug-eluting stents and beta-radiation for the treatment of diffuse in-stent restenosis: clinical and angiographic outcomes.
    Zavalloni D; Belli G; Rossi ML; Scatturin M; Morenghi E; Catalano G; Tosi G; Gasparini GL; Pagnotta P; Presbitero P
    Am Heart J; 2006 Nov; 152(5):908.e1-7. PubMed ID: 17070155
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Predictors of in-stent restenosis in coronary heart disease patients complicating with diabetes mellitus within 2 years after drug-eluting stents implantation].
    Chen J; Chen Y; Tian F; Han Y; Jing J; Liu J; Wang J; Zhou S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jan; 42(1):14-8. PubMed ID: 24680263
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intracoronary 166Holmium brachytherapy combined with cutting balloon angioplasty for the treatment of in-stent restenosis.
    Park S; Kang WC; Rhee JH; Ko YG; Choi D; Jang Y; Lee JD; Shim WH; Cho SY
    Cardiovasc Radiat Med; 2003; 4(3):119-25. PubMed ID: 14984711
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes.
    Paramasivam G; Devasia T; Jayaram A; U K AR; Rao MS; Vijayvergiya R; Nayak K
    Anatol J Cardiol; 2020 Jan; 23(1):28-34. PubMed ID: 31911567
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of Patients With Recurrent Coronary In-stent Restenosis With Failed Intravascular Brachytherapy.
    Yerasi C; Chen Y; Case BC; Forrestal BJ; Shea C; Zhang C; Torguson R; Ben-Dor I; Satler LF; Waksman R
    Am J Cardiol; 2021 Mar; 142():44-51. PubMed ID: 33285089
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study.
    Redfors B; Généreux P; Witzenbichler B; Maehara A; Weisz G; McAndrew T; Mehran R; Kirtane AJ; Stone GW
    Am Heart J; 2018 Mar; 197():142-149. PubMed ID: 29447774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Schwalm T; Carlsson J; Meissner A; Lagerqvist B; James S
    EuroIntervention; 2013 Sep; 9(5):564-72. PubMed ID: 24058074
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravascular ultrasound-guided high-pressure balloon predilatation for optimal drug-eluting stent deployment in restenosis of a stent implanted 7 years earlier. Do we know the right technique for in-stent restenosis restenting?
    Kalińczuk L; Demkow M; Ruzyłło W
    J Invasive Cardiol; 2008 May; 20(5):E139-45. PubMed ID: 18460715
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Northwell intracoronary brachytherapy for the treatment of recurrent drug eluting stent in-stent restenosis (NITDI study group).
    Meraj PM; Patel K; Patel A; Doshi R; Srinivas G; Jauhar R; Kaplan B; Garzon R; Sharma A; Cao Y; Diaz Molina F; Sharma R
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):41-46. PubMed ID: 31930652
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Meta-analysis of same versus different stent for drug-eluting stent restenosis.
    Vyas A; Schweizer M; Malhotra A; Karrowni W
    Am J Cardiol; 2014 Feb; 113(4):601-6. PubMed ID: 24342760
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Efficiency of endovascular re-interventions for evolving restenosis of different types of stents].
    Gerasimov AM; Cherkavskaia OV; Rudenko BA; Ageev FT; Savchenko AP
    Vestn Rentgenol Radiol; 2012; (1):21-7. PubMed ID: 22679810
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In-Stent Restenosis of Drug-Eluting Stents Compared With a Matched Group of Patients With De Novo Coronary Artery Stenosis.
    Buchanan KD; Torguson R; Rogers T; Xu L; Gai J; Ben-Dor I; Suddath WO; Satler LF; Waksman R
    Am J Cardiol; 2018 Jun; 121(12):1512-1518. PubMed ID: 29627111
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management of total restenotic occlusions.
    Werner GS; Moehlis H; Tischer K
    EuroIntervention; 2009 May; 5 Suppl D():D79-83. PubMed ID: 19736077
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis.
    Megaly M; Glogoza M; Xenogiannis I; Vemmou E; Nikolakopoulos I; Omer M; Willson L; Monyak DJ; Sullivan P; Stanberry L; Chavez I; Mooney M; Traverse J; Wang Y; Garcia S; Poulose A; Burke MN; Brilakis ES
    Cardiovasc Revasc Med; 2021 Jan; 22():29-33. PubMed ID: 32571761
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis.
    Megaly M; Glogoza M; Xenogiannis I; Vemmou E; Nikolakopoulos I; Willson L; Monyak DJ; Sullivan P; Stanberry L; Sorajja P; Chavez I; Mooney M; Traverse J; Wang Y; Garcia S; Poulose A; Burke MN; Brilakis ES
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):32-38. PubMed ID: 31943747
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    Zeng WP; Zhang R; Li R; Luo JF; Hu XF
    PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exacerbated Peri-Stent Contrast Staining on Serial Angiography and Optical Coherence Tomography After Platinum-Chromium Everolimus-Eluting Stent Implantation for Infrapopliteal Artery Lesions.
    Tomoi Y; Kuramitsu S; Soga Y; Hiramori S; Ando K
    Int Heart J; 2018 Jul; 59(4):895-898. PubMed ID: 29794389
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Progress in genetic and epigenetic research on in-stent restenosis after percutaneous coronary interventions].
    Kang YH; Lao HY; Yu XY; Chen JY; Zhong SL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):38-42. PubMed ID: 22311489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.